Baenninger Philipp B, Voegeli Susanne, Bachmann Lucas M, Faes Livia, Iselin Katja, Kaufmann Claude, Thiel Michael A
Department of Ophthalmology, Cantonal Hospital of Lucerne, Lucerne, Switzerland.
Medignition Inc, Research Consultants Zurich, Zurich, Switzerland.
Cornea. 2018 Jul;37(7):938-945. doi: 10.1097/ICO.0000000000001562.
To assess the variability of osmolarity measured by the point-of-care TearLab system in healthy eyes.
A systematic review was performed by searching MEDLINE, Scopus, and the Web of Science Databases until November 2016 and checking reference lists of included articles and reviews. The requirements for inclusion were the availability of TearLab results in healthy subjects and a minimum study sample of 20 eyes. Two reviewers assessed articles against the inclusion criteria, extracted relevant data, and examined the methodological quality. We computed the weighted mean osmolarity using the study size as the weighting factor and calculated the rate of subjects with osmolarity values >308 mOsm/L, the Dry Eye Workshop Report 2017 (DEWS) cut-off value for dry eye disease (DED). We repeated the analysis after excluding reports with a possible conflict of interest or missing description of subject selection.
Searches retrieved 105 nonduplicate articles, and we included 33 studies investigating 1362 eyes of healthy participants who were asymptomatic and showed no clinical signs of DED. Sixty-three percent were female, and mean age was 37.3 years (range: 21.5-69.0 yr). Weighted mean osmolarity was 298 mOsm/L (95% confidence interval, 282-321 mOsm/L). The result of the subgroup analysis was similar. Overall, 386 of 1362 eyes (28.3%) fulfilled the DEWS's definition of DED (>308 mOsm/L).
There is a high variability of osmolarity measurements with the TearLab system. A substantial number of healthy subjects fulfill the DEWS's definition of DED. We propose interpreting the TearLab osmolarity results cautiously and in the context of other established methods.
评估使用即时检测的TearLab系统测量健康眼睛渗透压的变异性。
通过检索MEDLINE、Scopus和科学网数据库至2016年11月,并检查纳入文章和综述的参考文献列表,进行系统评价。纳入标准为提供健康受试者的TearLab检测结果且最小研究样本量为20只眼。两名评价者根据纳入标准评估文章,提取相关数据,并检查方法学质量。我们以研究样本量作为权重因子计算加权平均渗透压,并计算渗透压值>308 mOsm/L(2017年干眼研讨会报告(DEWS)中干眼疾病(DED)的临界值)的受试者比例。在排除可能存在利益冲突或未描述受试者选择的报告后,重复上述分析。
检索到105篇非重复文章,我们纳入了33项研究,共调查了1362只健康参与者的眼睛,这些参与者无症状且无DED的临床体征。其中63%为女性,平均年龄为37.3岁(范围:21.5 - 69.0岁)。加权平均渗透压为298 mOsm/L(95%置信区间,282 - 321 mOsm/L)。亚组分析结果相似。总体而言,1362只眼中有386只(28.3%)符合DEWS对DED的定义(>308 mOsm/L)。
TearLab系统测量的渗透压存在高度变异性。大量健康受试者符合DEWS对DED的定义。我们建议谨慎解读TearLab渗透压检测结果,并结合其他既定方法进行综合判断。